Acceptance of pharmaceutical cannabis substitution by cannabis using patients with schizophrenia
Abstract Background Cannabis-smoking patients with a psychotic disorder have poorer disease outcomes than non-cannabis-smoking patients with poorest outcomes in patients smoking high-potency cannabis (HPC) containing high Δ9-tetrahydrocannabinol (THC) and low cannabidiol (CBD). Quitting cannabis smo...
Saved in:
Main Authors: | Jan van Amsterdam (Author), Jojanneke Vervloet (Author), Gerdien de Weert (Author), Victor J. A. Buwalda (Author), Anna E. Goudriaan (Author), Wim van den Brink (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2018-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia
by: Schaub Michael, et al.
Published: (2010) -
Cannabis as a substitute for alcohol and other drugs
by: Reiman Amanda
Published: (2009) -
New Perspectives in the Studies on Endocannabinoid and Cannabis: Cannabinoid Receptors and Schizophrenia
by: Hiroshi Ujike, et al.
Published: (2004) -
Exploring the substitution of cannabis for alcohol and other drugs among a large convenience sample of people who use cannabis
by: Chris Wilkins, et al.
Published: (2024) -
Association of cannabis use during adolescence, prefrontal CB1 receptor signaling and schizophrenia
by: Adriana eCaballero, et al.
Published: (2012)